Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid...

Area of Science:

• Oncology
• Genetics
• Endocrinology

Background:

• Multiple endocrine neoplasia type 2 (MEN 2) is linked to RET proto-oncogene mutations.
• Previously identified 'second hit' mechanisms include chromosome 10 abnormalities affecting RET alleles.
• Some MEN 2 tumors lack these known mechanisms, suggesting alternative pathways.

Purpose of the Study:

• To investigate alternative tumorigenesis mechanisms in MEN 2-associated medullary thyroid carcinoma.
• To analyze the TT cell line, derived from MEN 2, with a known RET germline mutation (codon 634).

Main Methods:

• Genomic DNA analysis to assess mutant vs. wild-type RET ratios.
• Fluorescence in situ hybridization (FISH) to detect chromosomal abnormalities (e.g., trisomy 10, chromosome 10 loss).
• Analysis of mutant RET mRNA production.

Main Results:

• The TT cell line showed a 2:1 ratio of mutant to wild-type RET at the DNA level.
• FISH analysis excluded trisomy 10 or loss of chromosome 10.
• A tandem duplication was identified as the cause of mutant RET amplification.
• Genomic alterations led to increased mutant RET mRNA production.

Conclusions:

• A third 'second hit' mechanism for MEN 2 tumorigenesis has been identified.
• This mechanism involves tandem duplication leading to mutant RET overrepresentation and overexpression.
• This discovery provides new insights into MEN 2 pathogenesis and potential therapeutic strategies.